advisorsecurities master

MENSJyong Biotech Ltd. Ordinary Shares

CSNasdaq (XNAS)·USD

Identity

Security key
18456
Ticker
MENS
Type
CSCommon Stock
Exchange
Nasdaq(XNAS)
Venue group
NASDAQ
Operating MIC
XNAS
Market
stocks
Locale
us
Currency
USD
Listed
2025-06-17
Round lot
100
Active
Yes
Last seen in a load
2026-08-14 20:49
Vendor updated
2026-08-13 06:09
Ticker root / suffix
MENS

Detail

Enriched 2026-08-14 20:47

Market cap
$151,436,680.68
Shares outstanding (class)
76,027,667
Shares outstanding (weighted)
74,233,667
SIC
Employees
27
Location
Description

Jyong Biotech Ltd is research and develop new drugs for today's great unmet medical needs and planned to manufacture and sell new drugs after receiving regulatory approval. It is a science-driven biotechnology company based in Taiwan and are committed to developing and commercializing and differentiated new drugs (plant-derived) mainly specializing in the treatment of urinary system diseases, with an initial focus on the markets of the U.S., the EU and Asia. The Group operates and manages its business as a single segment in the research and development of novel therapeutics targeting unmet needs. The company's product pipeline includes MCS-2, PCP, IC.

Market cap and share counts drift.

Funds holding this security

Identifiers

Classification

Fund data